Pharmaniaga Berhad (KLSE:PHARMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.280
-0.015 (-5.08%)
At close: Mar 2, 2026
24.44%
Market Cap 1.84B
Revenue (ttm) 3.93B
Net Income (ttm) 48.51M
Shares Out 6.56B
EPS (ttm) 0.01
PE Ratio 20.90
Forward PE 15.14
Dividend n/a
Ex-Dividend Date n/a
Volume 81,064,700
Average Volume 63,796,220
Open 0.285
Previous Close 0.295
Day's Range 0.275 - 0.290
52-Week Range 0.130 - 0.340
Beta 0.99
RSI 40.25
Earnings Date Feb 27, 2026

About Pharmaniaga Berhad

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and installation of medical and hospital equipment. The company also manufactures and sells generic drugs; conducts research and development of pharmaceutic... [Read more]

Industry Drug Stores and Proprietary Stores
Founded 1994
Employees 3,502
Stock Exchange Bursa Malaysia
Ticker Symbol PHARMA
Full Company Profile

Financial Performance

In 2025, Pharmaniaga Berhad's revenue was 3.93 billion, an increase of 4.48% compared to the previous year's 3.76 billion. Earnings were 48.51 million, a decrease of -63.20%.

Financial Statements

News

There is no news available yet.